arrow
E

Elisa Bianchi

Istituto di Ricerche Farmacologiche Mario Negri
H指数:29
被引数:2,735

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Air pollutants and amyotrophic lateral sclerosis in a population-based registry: investigating disease susceptibility, progression and survival

空气污染物与基于人群登记的肌萎缩侧索硬化症:探究疾病易感性、进展和生存情况

2026-05-280
PRE
Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis

后COVID-19神经肌肉状况的患病率及演变轨迹:一项系统综述和荟萃分析

2025-12-250
PRE
Understanding Long-Term Survival in ALS: A Cohort Study on Subject Characteristics and Prognostic Factors

理解ALS的长期生存:一项关于受试者特征和预后因素的研究队列

2025-10-170
OAAI
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy

多灶性运动神经病中传导阻滞以外的神经传导异常。对诊断标准准确性的影响

2025-09-230
OAAI
Utility and limitations of homemade videos in differentiating functional seizures from other paroxysmal events: An Italian cohort study

自制视频在区分功能性癫痫与其他发作性事件中的效用与局限性:一项意大利队列研究

2025-04-280
OAAI
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study

额颞痴呆的患病习惯和风险: 一项病例对照回顾性研究

2025-02-067
PREAI
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX)

新型冠状病毒肺炎疫苗与神经系统疾病 (COVIVAX) 相关性的多中心病例对照研究

2025-02-040
OAAI
Rituximab versus placebo for chronic inflammatory demyelinating polyradiculoneuropathy: a randomized trial

利妥昔单抗对比安慰剂治疗慢性炎症性脱髓鞘性多发性神经根神经病:一项随机试验

BRAIN
IF11.7
2024-12-102
PRE
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis

Post-COVID-19神经系统表现的患病率和轨迹: 系统回顾和荟萃分析

2024-01-259
PRE
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants

新型冠状病毒肺炎感染前奥米科变种的住院患者神经系统疾病的发生率和长期功能结局

2023-08-2927
OAAI
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy
2022-09-0816
OA